Wang L J, Zhang Y M, Deng Y L, Zheng H, Pan C, Shen Z Y
Department of Hepatobiliary Surgery, Tianjin First Center Hospital, Tianjin 300192, China.
Zhonghua Yi Xue Za Zhi. 2016 Jul 12;96(26):2091-3. doi: 10.3760/cma.j.issn.0376-2491.2016.26.011.
To analyse and explore the indications and efficacy of liver transplantation for benign liver tumor.
From Jan.2001 to Dec.2014, 6 patients, incluing 3 males and 3 females, with benign liver tumor underwent liver transplantation in our department.There were 2 cases of hepatic epithelioid hemangioendothelioma, 1 case of hepatic cavernous hemangioma, 1 case of liver mesenchymal hamartoma, 1 case of hilar bile duct mucinous cystadenoma, and 1 case of hepatic adenoma. The data of surgical procedure, perioperative complications, postoperative management, and the outcome of follow-up were analyzed.
Six orthotopic liver transplantation from one living donor and five cadaveric donors were performed. One patient died in the perioperative period, and other patients were discharged with normal liver and kidney function. Within the follow-up time of 22 to 88 months, these patients could live the normal lives with stable graft function and nutritional status.
Liver transplantation is the most efficient treatment for unresectable and symptomatic benign lesions, with the favourable outcome.
分析和探讨肝移植治疗良性肝肿瘤的适应证及疗效。
2001年1月至2014年12月,我科对6例良性肝肿瘤患者行肝移植术,其中男性3例,女性3例。包括肝上皮样血管内皮瘤2例、肝海绵状血管瘤1例、肝脏间叶性错构瘤1例、肝门部胆管黏液性囊腺瘤1例、肝腺瘤1例。分析手术过程、围手术期并发症、术后处理及随访结果等资料。
共施行6例原位肝移植术,其中活体供肝1例,尸体供肝5例。1例患者围手术期死亡,其余患者肝功能及肾功能正常出院。随访22至88个月,患者移植肝功能稳定,营养状况良好,均能正常生活。
肝移植是治疗无法切除且有症状的良性肝脏病变最有效的方法,疗效良好。